Literature DB >> 10363546

Efficacy of microsurgical free-tissue transfer in chronic osteomyelitis of the leg and foot: review of 22 cases.

R Musharafieh1, O Osmani, U Musharafieh, S Saghieh, B Atiyeh.   

Abstract

The efficacy of free composite tissue transfer for the treatment of chronic osteomyelitis of the leg and foot was evaluated in a retrospective study. Twenty-two patients, operated on at the American University of Beirut between January, 1992 and December, 1996, were identified. Infection involved the heel (8), ankle (1), foot (5), and tibia (8). All patients had multiple debridement and prolonged antibiotic treatment prior to presentation. The mean duration of disease was 4.8 years (range: 1 to 25 years). There were five cases of infected tibial non-union and one case of an infected tibial bone defect measuring 15 cm. Following radical debridement, microvascular free-tissue transfer was immediately performed. One latissimus dorsi and 13 rectus abdominis muscle flaps, as well as eight radial forearm fasciocutaneous flaps were used. At a mean follow-up of 3.8 years, there was one rectus abdominis free-flap failure in a Gustilo IIIC tibial fracture, which necessitated secondary amputation; there was no evidence of recurrence of osteomyelitis in the remaining 21 patients during the study period. The patients with tibial nonunion and bone defect healed following resection and bone transport utilizing a callus distraction technique. The results show that free-tissue transfer is a safe and viable treatment option in chronic osteomyelitis of the leg and foot. A brief discussion of the history of microvascular free-tissue transfers, as well as their value in modern reconstructive surgery, is also presented.

Entities:  

Mesh:

Year:  1999        PMID: 10363546     DOI: 10.1055/s-2007-1000097

Source DB:  PubMed          Journal:  J Reconstr Microsurg        ISSN: 0743-684X            Impact factor:   2.873


  8 in total

1.  Reconstruction of Large Diaphyseal Defects of the Femur and the Tibia with Autologous Bone.

Authors:  Charles E Dumont; Ulrich G Exner
Journal:  Eur J Trauma Emerg Surg       Date:  2009-01-19       Impact factor: 3.693

2.  Cost-effectiveness of using Polyheal compared with surgery in the management of chronic wounds with exposed bones and/or tendons due to trauma in France, Germany and the UK.

Authors:  Julian F Guest; Erikas Sladkevicius; Monica Panca
Journal:  Int Wound J       Date:  2013-03-13       Impact factor: 3.315

3.  Factors affecting the outcome of lower extremity osteomyelitis treated with microvascular free flaps: an analysis of 65 patients.

Authors:  Duy Quang Thai; Yeon Kyo Jung; Hyung Min Hahn; Il Jae Lee
Journal:  J Orthop Surg Res       Date:  2021-08-27       Impact factor: 2.359

4.  Baclofen pump pocket infection: a case report of successful salvage with muscle flap.

Authors:  Bishara S Atiyeh; Shady N Hayek; Ghassan S Skaf; Ali Al Araj; Roukoz B Chamoun
Journal:  Int Wound J       Date:  2006-03       Impact factor: 3.315

5.  Latissimus dorsi free flap salvage of recurrent chronic osteomyelitis with simultaneous elbow interposition arthroplasty.

Authors:  Mark Henry
Journal:  Hand (N Y)       Date:  2007-07-14

Review 6.  [Plastic surgical reconstruction methods in interdisciplinary treatment of chronic wounds].

Authors:  T Kremer; G Germann; K Riedel; G A Giessler
Journal:  Chirurg       Date:  2008-06       Impact factor: 0.920

7.  Two-team-approached free flap reconstruction for plantar malignant melanoma: An observational (STROBE-compliant) trial.

Authors:  Jun Hyeok Kim; Chae Rim Lee; Hyo Jeong Kwon; Deuk Young Oh; Young-Joon Jun; Jong Won Rhie; Suk-Ho Moon
Journal:  Medicine (Baltimore)       Date:  2022-07-29       Impact factor: 1.817

8.  Combined Orthoplastic Approach in Fracture-Related Infections of the Distal Tibia.

Authors:  Andrea Sambri; Marco Pignatti; Sara Tedeschi; Maria Elisa Lozano Miralles; Claudio Giannini; Michele Fiore; Matteo Filippini; Riccardo Cipriani; Pierluigi Viale; Massimiliano De Paolis
Journal:  Microorganisms       Date:  2022-08-12
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.